3 years ago

Enhanc3D Genomics Secures £10M Series A Funding to Advance 3D Genomics Platform

  • Enhanc3D Genomics, a functional genomics company based in Cambridge, UK, has raised £10 million in Series A funding led by BGF, with participation from Parkwalk Advisors and Bioqube Ventures

  • The company plans to use the funds to accelerate the development of its proprietary technology platform, GenLink3D, which aims to unlock the potential of the three-dimensional organization of DNA

  • Enhanc3D's technology directly measures DNA interactions controlling gene regulation, allowing the exploration of the uncharted non-coding regions of the DNA

  • The platform will initially generate large datasets across multiple immune-cell types that have broad relevance to auto-immune diseases, cancer and ageing.

      • ProblemBiotechnology

      "unlock the potential of the three-dimensional organisation of DNA, explore the uncharted non-coding regions of the DNA, which account for about 98%"

      Solution

      "GenLink3D platform, directly measures DNA interactions controlling gene regulation, generates large datasets across multiple immune-cell types, has broad relevance to auto-immune diseases, cancer and ageing"

      Covered on